Clincosm LogoSign in Get a demo

Stage IV Melanoma

Showing 26 - 50 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Orange (Pazopanib and Paclitaxel)

Completed
Has Results
  • Stage III Melanoma
  • +2 more
  • Pazopanib and Paclitaxel
  • Orange, California
    Chao Family Comprehensive Cancer Center
Aug 5, 2019

Stage IV Melanoma Trial in Brisbane (Coxsackievirus A21)

Completed
  • Stage IV Melanoma
  • Coxsackievirus A21
  • Brisbane, Queensland, Australia
    Princess Alexandra Hospital
Jun 26, 2019

Unresectable Malignant Tumor, Melanoma, Metastatic Melanoma Trial in Saint Louis (Pembrolizumab)

Completed
Has Results
  • Unresectable Malignant Neoplasm
  • +4 more
  • Saint Louis, Missouri
    Saint Louis University Hospital
Jun 3, 2019

Stage IV Melanoma, Stage III Melanoma Trial in United States (Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC),

Terminated
  • Stage IV Melanoma
  • Stage III Melanoma
  • Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)
  • Autologous PBMCs in GM-CSF (MC)
  • Irvine, California
  • +17 more
May 9, 2019

Stage IIIC Melanoma, Stage IV Melanoma Trial in United States (Denileukin diftitox)

Completed
  • Stage IIIC Melanoma
  • Stage IV Melanoma
  • Denileukin diftitox
  • Encinitas, California
  • +9 more
Feb 28, 2019

Liver Metastases, Lung Metastases, Recurrent Melanoma Trial in Columbus (biological, radiation, other)

Unknown status
  • Liver Metastases
  • +4 more
  • ipilimumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 19, 2018

Stage IIIC Skin Melanoma, Stage IV Melanoma Trial in Cleveland (lymph node, X-ACT)

Terminated
  • Stage IIIC Skin Melanoma
  • Stage IV Melanoma
  • lymph node
  • X-ACT
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
Dec 5, 2018

Stage IV Melanoma Trial in Louisville, Philadelphia, Houston (LC beads loaded with Doxorubicin)

Completed
Has Results
  • Stage IV Melanoma
  • LC beads loaded with Doxorubicin
  • Louisville, Kentucky
  • +2 more
Sep 28, 2018

Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Rochester (drug, biological, other)

Completed
  • Recurrent Melanoma
  • +7 more
  • Montanide ISA 51 VG
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 4, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +13 more
  • ipilimumab
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 4, 2018

Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,

Completed
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +10 more
  • cediranib maleate
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 27, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in Philadelphia (drug, biological, other)

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • imatinib mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
May 23, 2018

Extraocular Extension Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma Trial in Buffalo (axitinib,

Terminated
Has Results
  • Extraocular Extension Melanoma
  • +11 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 8, 2018

Stage IV Melanoma Trial in Minneapolis (aldesleukin, allogeneic large multivalent immunogen vaccine)

Completed
Has Results
  • Stage IV Melanoma
  • aldesleukin
  • allogeneic large multivalent immunogen vaccine
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

BRAFV600 Mutation, Stage IV Melanoma Trial in Salt Lake City (Radiation therapy, Vemurafenib)

Withdrawn
  • BRAFV600 Mutation
  • Stage IV Melanoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute
May 22, 2017

Recurrent Melanoma, Stage IV Melanoma Trial in Seattle (biological, drug, procedure, other, genetic)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • ipilimumab
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Nashville (diagnostic test, other, device)

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • [18F]fluorodeoxyglucose
  • +3 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 12, 2017

Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma Trial in Boston (dinaciclib, pharmacological study, laboratory

Terminated
Has Results
  • Stage IIIB Melanoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 3, 2017

Recurrent Melanoma, Stage IV Melanoma Trial in Seattle (biological, drug, procedure, other, genetic)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • therapeutic autologous lymphocytes
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 13, 2017

Stage IV Melanoma Trial in Louisville (A-dmDT390-bisFv(UCHT1), Pembrolizumab, Ionizing Radiation)

Unknown status
  • Stage IV Melanoma
  • A-dmDT390-bisFv(UCHT1)
  • +2 more
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Dec 12, 2016

Stage IV Melanoma Trial in Orange (Disulfiram (DSF))

Completed
  • Stage IV Melanoma
  • Disulfiram (DSF)
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 6, 2016

Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain Trial (Vemurafenib, Whole-brain radiation therapy (WBRT),

Withdrawn
  • Recurrent Melanoma
  • +2 more
  • (no location specified)
Oct 19, 2016

Stage IV Melanoma Trial in Worldwide (Lenvatinib, Dacarbazine)

Completed
Has Results
  • Stage IV Melanoma
  • Hagerstown, Maryland
  • +26 more
Aug 16, 2016

Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma Trial in United States

Terminated
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +6 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • laboratory biomarker analysis
  • Mobile, Alabama
  • +177 more
May 6, 2016